Predictions
Novo Nordisk A/S
Start price
Target price
Perf. (%)
€147.92
08.06.23
08.06.23
€170.00
08.06.24
08.06.24
26.29%
12.09.23
12.09.23
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€307.95
30.05.23
30.05.23
€356.18
30.05.24
30.05.24
35.46%
23.05.24
23.05.24
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€397.00
24.05.23
24.05.23
€464.75
24.05.24
24.05.24
89.39%
23.05.24
23.05.24
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€397.00
24.05.23
24.05.23
€462.89
24.05.24
24.05.24
89.39%
23.05.24
23.05.24
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€156.00
18.05.23
18.05.23
€169.00
09.08.24
09.08.24
-18.64%
23.05.24
23.05.24
AstraZeneca plc
Start price
Target price
Perf. (%)
€124.30
11.11.22
11.11.22
€165.00
08.09.26
08.09.26
21.39%
23.05.24
23.05.24
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
positive Cash Flow expected
Novo Nordisk A/S
Start price
Target price
Perf. (%)
€93.01
07.03.22
07.03.22
€195.00
18.07.24
18.07.24
109.54%
12.09.23
12.09.23
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€196.52
08.01.22
08.01.22
€915.00
14.01.27
14.01.27
112.27%
23.05.24
23.05.24
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
ROE higher than 15% per year
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€70.48
30.09.16
30.09.16
€98.00
08.09.26
08.09.26
11.09%
23.05.24
23.05.24
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued